# US 2008/0306359 A1 · Medical Diagnostic and Treatment Platform Using Near-Field Wireless Communication of Information Within a Patient's Body

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306359 A1
- Document ID: US20080306359A1
- Status: Published application
- Kind: A1
- Application number: 12/063,095
- Filed: 2006-09-01
- Published: 2008-12-11
- Earliest claimed: 2005-09-01
- Assignees: Proteus Digital Health, Inc.
- Inventors: Mark J. Zdeblick; Timothy Robertson
- Web page: https://patentgrep.com/patent/US20080306359A1

## CPC

- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/0028: {Body tissue as transmission medium, i.e. transmission systems where the medium is the human body}
- A61B 5/0031: {Implanted circuitry}
- A61B 5/026: Measuring blood flow {(A61B3/1233, A61B3/1241 take precedence)}
- A61B 5/0265: using electromagnetic means, e.g. electromagnetic flowmeter
- A61B 5/14535: {for measuring haematocrit}
- A61B 5/415: {the glands, e.g. tonsils, adenoids or thymus}
- A61B 5/418: {lymph vessels, ducts or nodes}
- A61B 5/6862: {Stents}
- A61B 5/6876: {Blood vessel}
- A61M 5/172: electrical or electronic
- A61N 1/37217: {characterised by the communication link, e.g. acoustic or tactile}
- A61N 1/37223: {Circuits for electromagnetic coupling}
- H02J 50/20: using microwaves or radio frequency waves
- A61B 5/01: Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20)
- A61B 5/0215: by means inserted into the body
- A61B 5/145: Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value {; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue} (non-radiation detecting or locating of foreign bodies in blood A61B5/06)
- H02J 2105/46: Medical devices, medical implants or life supporting devices
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- H02J: ELECTRIC POWER NETWORKS; CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention provides implantable systems that communicate wirelessly with each other using a unique format that enables devices configurations and applications heretofore not possible. Embodiments of the present invention provide communication apparatuses and methods for exchanging information with implantable medical devices. In some embodiments, two implantable devices communicate with each other using quasi-electrostatic signal transmission in a long wavelength/low frequency electromagnetic band, with the patient's body acting as a conductive medium.

## Claims

### Claim 1

A system for communicating information within the body of animal, the system comprising:
(a) a first device comprising a transmitter configured to transmit a signal via a quasi electrostatic coupling to the body of the patient; and
(b) a second device comprising a receiver configured to receive the transmitted signal via a quasi electrostatic coupling to the body of the patient.

### Claim 2 (depends on 1)

The system according to claim 1, wherein said system includes at least a third device which is configured to at least one of:
(i) transmit a signal via a quasi electrostatic coupling to the body of the patient; and
(ii) receive the transmitted signal via a quasi electrostatic coupling to the body of the patient.

### Claim 3 (depends on 1)

The system according to claim 1, wherein said signal comprises data produced by said first device.

### Claim 4 (depends on 1)

The system according to claim 1, wherein said signal comprises an identifier of said first device.

### Claim 5 (depends on 1)

The system according to claim 1, wherein said signal is used by said second device as a power source.

### Claim 6 (depends on 1)

The system according to claim 1, wherein said first device is an implantable medical device.

### Claim 7 (depends on 6)

The system according to claim 6, wherein said first device includes a sensor.

### Claim 8 (depends on 7)

The system according to claim 7, wherein said sensor is a blood flow sensor.

### Claim 9 (depends on 8)

The system according to claim 8, wherein said blood flow sensor comprises a resistivity sensor.

### Claim 10 (depends on 8)

The system according to claim 8, wherein said blood flow sensor comprises an electromagnetic blood flow sensor.

### Claim 11 (depends on 6)

The system according to claim 6, wherein said first device includes an effector.

### Claim 12 (depends on 11)

The system according to claim 11, wherein said effector comprises an electrode.

### Claim 13 (depends on 1)

The system according to claim 1, wherein the first device comprises an ingestible medical device.

### Claim 14 (depends on 1)

The system according to claim 1, wherein the first device is an external device configured to contact a surface of said animal.

### Claim 15 (depends on 1)

The system according to claim 1, wherein the second device is an implantable medical device.

### Claim 16 (depends on 15)

The system according to claim 15, wherein the second device is further configured to retransmit the received signal to a secondary receiver external to said patient.

### Claim 17 (depends on 16)

The system according to claim 16, wherein said secondary receiver is an RF receiver and comprises a radio frequency (RF) transmitter.

### Claim 18 (depends on 16)

The system according to claim 16, wherein said second device includes a transcutaneous wire configured to retransmit the received information to the secondary receiver.

### Claim 19 (depends on 16)

The system according to claim 16, wherein said secondary receiver is internal to said patient.

### Claim 20 (depends on 1)

The system according to claim 1, wherein the second device is a pacemaker.

### Claim 21

A communications device for use within a body of a patient, said communications device comprising:
(a) a power supply;
(b) a signal generating circuit coupled to said power supply and configured to generate a signal; and
(c) an antenna coupled to said signal generating circuit and configured to transmit said signal via quasi electrostatic coupling to said body.

### Claim 22 (depends on 21)

The communications device according to claim 21, wherein said power supply comprises a battery.

### Claim 23 (depends on 21)

The communications device according to claim 21, wherein said power supply comprises:
(i) an antenna configured to receive energy from an energy source via a quasi electrostatic coupling to said body; and
(ii) a converter circuit configured to convert the received energy to electrical power.

### Claim 24 (depends on 21)

The communications device according to claim 21, wherein said antenna comprises a pair of electrodes separated by a gap.

### Claim 25 (depends on 21)

The communications device according to claim 21, wherein said signal generating circuit is further configured to generate a signal representing information.

### Claim 26 (depends on 25)

The communications device according to claim 25, wherein said signal generating circuit comprises an oscillator coupled to said antenna.

### Claim 27 (depends on 26)

The communications device according to claim 26, wherein said oscillator is configured to operate at a frequency such that a radiation field generated by the antenna has a wavelength more than 10 times longer than a largest dimension of said body.

### Claim 28 (depends on 27)

The communications device according to claim 27, wherein said oscillator is configured to operate at a frequency of about 10 MHz or less.

### Claim 29 (depends on 28)

The communications device according to claim 28, wherein said oscillator is configured to operate at a frequency of between about 300 Hz and about 1 MHz.

### Claim 30 (depends on 21)

The communications device according to claim 21, wherein said signal generating circuit comprises:
(i) a driver coupled to drive a time varying potential on said antenna;
(ii) an oscillator having an output coupled to said driver; and
(iii) a modulator configured to modulate a frequency of the oscillator output so as to encode the information.

### Claim 31 (depends on 21)

The communications device according to claim 21, wherein said signal generating circuit comprises:
(i) a driver coupled to drive a time varying potential on said antenna;
(ii) an oscillator having an output coupled to said driver; and
(ii) a modulator configured to modulate a phase of said oscillator output so as to encode the information.

### Claim 32 (depends on 21)

The communications device according to claim 21, wherein said signal generating circuit includes:
(i) a driver coupled to drive a time varying potential on said antenna;
(ii) an oscillator having an output coupled to said driver; and
(iii) a modulator configured to modulate an amplitude of said oscillator output so as to encode the information.

### Claim 33 (depends on 21)

The communications device according to claim 21, wherein device is an implantable medical device.

### Claim 34 (depends on 33)

The communications device according to claim 33, wherein said device includes a sensor.

### Claim 35 (depends on 34)

The communications device according to claim 34, wherein said sensor is a blood flow sensor.

### Claim 36 (depends on 35)

The communications device according to claim 35, wherein said blood flow sensor comprises a resistivity sensor.

### Claim 37 (depends on 35)

The communications device according to claim 35, wherein said blood flow sensor comprises an electromagnetic blood flow sensor.

### Claim 38 (depends on 33)

The communications device according to claim 33, wherein said device includes an effector.

### Claim 39 (depends on 38)

The communications device according to claim 38, wherein said effector comprises an electrode.

### Claim 40 (depends on 21)

The communications device according to claim 21, wherein the device is an ingestible medical device.

### Claim 41 (depends on 21)

The communications device according to claim 21, wherein said device is a pharmaceutical delivery device.

### Claim 42

A method for communicating information within a body of a patient, said method comprising:
(a) operating a transmitter of a device located within said body to generate a quasi electrostatic signal; and
(b) detecting said quasi electrostatic signal using a receiver.

### Claim 43 (depends on 42)

The method according to claim 42, wherein said receiver is disposed within said body.

### Claim 44 (depends on 42)

The method according to claim 42, wherein said receiver is in contact with an external surface of said body.

### Claim 45 (depends on 42)

The method according to claim 42, wherein said device is an implantable medical device.

### Claim 46 (depends on 45)

The method according to claim 45, wherein said device includes a sensor.

### Claim 47 (depends on 46)

The method according to claim 46, wherein said sensor is a blood flow sensor.

### Claim 48 (depends on 47)

The method according to claim 47, wherein said blood flow sensor is a resistivity sensor.

### Claim 49 (depends on 47)

The method according to claim 47 wherein said blood flow sensor is an electromagnetic blood flow sensor.

### Claim 50 (depends on 45)

The method according to claim 45, wherein said device includes an effector.

### Claim 51 (depends on 50)

The method according to claim 50, wherein said actuator comprises an electrode.

### Claim 52 (depends on 42)

The method according to claim 42, wherein the device is an ingestible medical device.

### Claim 53

A kit comprising at least one of:
(a) a first device comprising a transmitter configured to transmit a signal via a quasi electrostatic coupling to a body of a patient; and
(b) a second device comprising a receiver configured to receive the transmitted signal via a quasi electrostatic coupling to said body.

### Claim 54 (depends on 53)

The kit according to claim 53, wherein said kit comprises both of said first and second devices.

### Claim 55

An implantable fluid flow sensor comprising:
(a) a substrate;
(b) a pair of current flow electrodes disposed on a top surface of said substrate;
(c) a current source on said substrate and configured to transfer charge between said first and second current flow electrodes;
(d) a pair of sense electrodes disposed on said top surface of the substrate between said flow terminals and separated by a distance S; and
(e) a detection circuit on said substrate configured to:
(i) detect a potential difference between said sense electrodes, the potential difference correlating to a resistivity of flowing blood, and
(ii) produce an output signal at an output node, the output signal correlating to the potential difference.

### Claim 56 (depends on 55)

The implantable blood flow sensor according to claim 55, further comprising a transmitter unit coupled to said output node of the detection circuit and configured to transmit said output signal to a data collector.

### Claim 57 (depends on 56)

The implantable blood flow sensor according to claim 56, wherein said transmitter unit is configured to transmit via quasi electrostatic coupling into a conductive tissue of a body of a patient.

### Claim 58 (depends on 55)

The implantable blood flow sensor according to claim 55, further comprising a power supply unit configured to supply power to said current source and said detection circuit.

### Claim 59 (depends on 55)

The implantable blood flow sensor according to claim 55, wherein said distance S is about 10 microns or less.

### Claim 60 (depends on 55)

The implantable blood flow sensor according to claim 55, wherein said detection circuit is further configured to detect discrete potential variations resulting from passage of individual red blood cells.

### Claim 61 (depends on 55)

The implantable blood flow sensor according to claim 55, wherein said sensor is present on a lead.

### Claim 62 (depends on 61)

The implantable blood flow sensor according to claim 61, wherein said lead is a multiplex lead.

### Claim 63 (depends on 55)

The implantable blood flow sensor according to claim 55, wherein said sensor is not present on a lead.

### Claim 64 (depends on 1, 55)

The implantable blood flow sensor according to claim 55, wherein said sensor is part of a system according to claim 1.

### Claim 65 (depends on 55)

The implantable blood flow sensor according to claim 55, wherein said sensor is configured to detect a potential difference at two different frequencies.

### Claim 66

A method of determining a physiological parameter of a patient, said method comprising:
(a) obtaining a resistivity measure from a fluid flow sensor implanted in a blood vessel of said a patient; and
(b) processing said resistivity measure to determine said physiological parameter.

### Claim 67 (depends on 66)

The method according to claim 66, wherein said processing is performed by a data collector.

### Claim 68 (depends on 67)

The method according to claim 67, wherein said data collector is remote from said sensor.

### Claim 69 (depends on 68)

The method according to claim 68, wherein said resistivity measure is wirelessly communicated from said sensor to said data collector using a wireless communication protocol.

### Claim 70 (depends on 69)

The method according to claim 69, wherein said wireless communication protocol comprises using quasi electrostatic coupling to a conductive tissue of said patient.

### Claim 71 (depends on 67)

The method according to claim 67, wherein said data collector is implanted in or attached to the patient's body.

### Claim 72 (depends on 71)

The method according to claim 71, wherein said data collector is part of a pacemaker can.

### Claim 73 (depends on 72)

The method according to claim 72, wherein said data collector comprises a wearable unit including electrodes attachable to the patient's skin and configured to detect quasi electrostatic signals propagating in the body of the patient.

### Claim 74 (depends on 66)

The method according to claim 66, wherein said physiological parameter corresponds to a blood flow velocity.

### Claim 75 (depends on 66)

The method according to claim 66, wherein said physiological parameter corresponds to hematocrit.

### Claim 76 (depends on 66)

The method according to claim 66, wherein said physiological parameter corresponds to a stroke volume.

### Claim 77 (depends on 66)

The method according to claim 66, further comprising performing a remedial action based on said physiological parameter.

### Claim 78 (depends on 77)

The method according to claim 77, wherein said remedial action comprises administering a pharmaceutical agent to said patient.

### Claim 79 (depends on 78)

The method according to claim 78, wherein said remedial action comprises administering a electrical stimulation to said patient.

### Claim 80 (depends on 78)

The method according to claim 78, wherein said remedial action comprises alerting said patient to seek medical attention.

### Claim 81 (depends on 66)

The method according to claim 66, wherein said method comprises detecting a potential difference at two different frequencies.

### Claim 82

A kit comprising:
(A) an implantable blood flow sensor comprising:
(i) a substrate;
(ii) a pair of current flow electrodes disposed on a top surface of said substrate;
(iii) a current source on said substrate and configured to transfer charge between said first and second current flow electrodes;
(iv) a pair of sense electrodes disposed on said top surface of the substrate between said flow terminals and separated by a distance S; and
(v) a detection circuit on said substrate configured to:
(a) detect a potential difference between said sense electrodes, the potential difference correlating to a resistivity of flowing blood, and
(b) produce an output signal at an output node, the output signal correlating to the potential difference; and
(B) a data collector.

### Claim 83

An implantable fluid flow sensor comprising:
(a) a pair of sense electrodes; and
(b) a detection circuit configured to:
(i) detect a potential difference between said sense electrodes, the potential difference resulting from an applied magnetic field to flowing fluid, and
(ii) produce an output signal at an output node, the output signal correlating to the detected potential difference.

### Claim 84 (depends on 83)

The implantable fluid flow sensor according to claim 83, wherein said applied magnetic field is an alternating current magnetic field having an alternating frequency and said detection circuit is configured to detect said potential difference at said alternating frequency.

### Claim 85 (depends on 83)

The implantable fluid flow sensor according to claim 83, wherein said sensor further comprises a magnetic field production element.

### Claim 86 (depends on 85)

The implantable fluid flow sensor according to claim 85, wherein said magnetic field production element comprises at least one pair of coils.

### Claim 87 (depends on 86)

The implantable fluid flow sensor according to claim 86, wherein said sensor further comprises a solid support and said pair of sense electrodes and pair of coils are present a same surface of said solid support.

### Claim 88 (depends on 87)

The implantable fluid flow sensor of claim 87, wherein said solid support is a structure having a planar surface and said sense electrodes and coils are present on said planar surface.

### Claim 89 (depends on 87)

The implantable fluid flow sensor of claim 87, wherein said solid support is a structure having a curvilinear surface, and said sense electrodes and coils are present on said curvilinear surface.

### Claim 90 (depends on 89)

The implantable fluid flow sensor of claim 89, wherein said solid support is a stent and said curvilinear surface is the inner surface of said stent.

### Claim 91 (depends on 89)

The implantable fluid flow sensor of claim 89, wherein said solid support is a lead and said curvilinear surface is the outer surface of said lead.

### Claim 92 (depends on 83)

The implantable fluid flow sensor of claim 83, wherein said sense electrodes are present on a lead.

### Claim 93 (depends on 92)

The implantable fluid flow sensor of claim 92, wherein said lead is a multiplex lead.

### Claim 94 (depends on 83)

The implantable fluid flow sensor according to claim 83, wherein said sense electrodes are not present on a lead.

### Claim 95 (depends on 1, 83)

The implantable fluid flow sensor according to claim 83, wherein said sensor is part of a system according to claim 1.

### Claim 96

A method of determining a physiological parameter of a patient, said method comprising:
(a) applying a magnetic field to a target fluid flow site of said patient;
(b) obtaining a potential difference measure from a pair of sense electrodes positioned at said target fluid flow site; and
(b) processing said potential difference measure to determine said physiological parameter.

### Claim 97 (depends on 96)

The method according to claim 96, wherein said magnetic field is applied to said target fluid flow site from a magnetic field source external to said patient.

### Claim 98 (depends on 96)

The method according to claim 96, wherein said magnetic field is applied to said target fluid flow site from a magnetic field source internal to said patient.

### Claim 99 (depends on 98)

The method according to claim 98, wherein said magnetic filed source and said sense electrodes are both present on a surface of a solid support.

### Claim 100 (depends on 99)

The method according to claim 99, wherein said surface is a planar surface.

### Claim 101 (depends on 99)

The method according to claim 99, wherein said surface is a curvilinear surface.

### Claim 102 (depends on 96)

The method according to claim 96, wherein said processing is performed by a data collector.

### Claim 103 (depends on 102)

The method according to claim 102, wherein said data collector is remote from said sense electrodes.

### Claim 104 (depends on 103)

The method according to claim 103, wherein said potential difference measure is wirelessly communicated from said sense electrodes to said data collector using a wireless communication protocol.

### Claim 105 (depends on 104)

The method according to claim 104, wherein said wireless communication protocol comprises using quasi electrostatic coupling to a conductive tissue of said patient.

### Claim 106 (depends on 105)

The method according to claim 105, wherein said protocol employs said sense electrodes as an antenna.

### Claim 107 (depends on 105)

The method according to claim 105, wherein said protocol employs one or more electrodes distinct from said sense electrodes as an antenna.

### Claim 108 (depends on 96)

The method according to claim 96, wherein said physiological parameter corresponds to a blood flow velocity.

### Claim 109 (depends on 96)

The method according to claim 96, further comprising performing a remedial action based on said physiological parameter.

### Claim 110 (depends on 109)

The method according to claim 109, wherein said remedial action comprises administering a pharmaceutical agent to said patient.

### Claim 111 (depends on 109)

The method according to claim 109, wherein said remedial action comprises administering an electrical stimulus to said patient.

### Claim 112 (depends on 109)

The method according to claim 109, wherein said remedial action comprises alerting said patient to seek medical attention.

### Claim 113

A kit comprising:
(1) an implantable fluid flow sensor comprising:
(a) a pair of sense electrodes; and
(b) a detection circuit configured to:
(i) detect a potential difference between said sense electrodes, the potential difference resulting from an applied magnetic field to flowing fluid, and
(ii) produce an output signal at an output node, the output signal correlating to the potential difference; and
(2) instructions for using said fluid flow sensor to determine a physiological parameter of a patient.
